| Q34252008 | 25 years' experience with the Biken Oka strain varicella vaccine: a clinical overview |
| Q44404409 | Antibody responses in recipients of varicella vaccine assayed by immunoblotting |
| Q41726417 | Antiviral prophylaxis and treatment in chickenpox. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection |
| Q34743424 | Clinical manifestations of varicella-zoster virus infection |
| Q37241346 | Clinicopathologic understanding and control of varicella-zoster virus infection |
| Q39685724 | Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus |
| Q45784125 | Detection of varicella-zoster virus DNA in blood of children with varicella |
| Q28757353 | Discriminating between varicella-zoster virus vaccine and wild-type strains by loop-mediated isothermal amplification |
| Q33709679 | Effect of oral acyclovir against primary and secondary viraemia in incubation period of varicella |
| Q41150938 | Immune responses to varicella-zoster virus |
| Q45776593 | Investigation of varicella-zoster virus DNA by the polymerase chain reaction in healthy children with varicella vaccination |
| Q45737429 | Investigation of varicella-zoster virus DNA in lymphocyte subpopulations by quantitative PCR assay |
| Q36827734 | Investigation of varicella-zoster virus infection of lymphocytes by in situ hybridization |
| Q33797830 | Modulation of major histocompatibility class II protein expression by varicella-zoster virus |
| Q36515070 | Molecular studies of Varicella zoster virus |
| Q41726436 | Occupational and infection control aspects of varicella. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection |
| Q34714480 | Pathogenesis of varicelloviruses in primates |
| Q45840818 | Placental transfer of IgG subclass-specific antibodies to varicella-zoster virus |
| Q33403576 | Platelet antigens in varicella associated thrombocytopenia |
| Q42129849 | Prophylaxis or modification of varicella by oral acyclovir after household exposure |
| Q34251697 | Recurrent 6th nerve palsy in a child following different live attenuated vaccines: case report |
| Q40748381 | Severity of human herpesvirus-6 viremia and clinical findings in infants with exanthem subitum |
| Q27334810 | T-Cell tropism of simian varicella virus during primary infection |
| Q41150983 | The varicella vaccine. Prevention of herpes zoster |
| Q71653718 | The varicella vaccine. Vaccine development |
| Q38761395 | Universal varicella vaccine immunization in Japan |
| Q64319445 | Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies |
| Q47607699 | Varicella and herpes zoster vaccine development: lessons learned |
| Q35626319 | Varicella zoster virus DNA in throat swabs |
| Q24683811 | Varicella-zoster virus |
| Q39188767 | Varicella-zoster virus infection and immunization in the healthy and the immunocompromised host |
| Q37880047 | Viral vaccines of the future. |
| Q54066095 | Viremia and neutralizing antibody response in infants with exanthem subitum. |
| Q33329009 | Virus-associated idiopathic thrombocytopenic purpura |
| Q79755659 | [Prophylaxis of varicella in pediatric staff.]. |